Effect of oral milrinone on end-systolic relations in patients with severe congestive heart failure

This publication has 29 references indexed in Scilit:

• Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.
  Circulation, 1987
• Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure.
  Circulation, 1986
• Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure
  Journal of the American College of Cardiology, 1986
• Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
  Circulation, 1986
• Milrinone in congestive heart failure: Acute and chronic hemodynamic and clinical evaluation
  Journal of the American College of Cardiology, 1985
• Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.
  Circulation, 1985
• Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
  Journal of Clinical Investigation, 1985
• Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart Failure
  New England Journal of Medicine, 1983
• Characterization of the Cardiotonic Effects of Milrinone, a New and Potent Cardiac Bipyridine, on Isolated Tissues from Several Animal Species
  Journal of Cardiovascular Pharmacology, 1983
• Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
  Circulation, 1983